Fumaric Acid

Fumaric Acid

SCHEMBL23927822

CN(C)CCn1ccc2ccccc21.O=C(O)/C=C/C(=O)O

nearest known ligand 0.75

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1ADRB2ATP4AATP4BAXLCHRM2CHRM3DRD2FLT3HRH1HTR2AHTR2BHTR2CKCNH2KMT2AMAP2K1MAP2K2MEN1MLNRPLK4RENS1PR1SLC6A2SLC6A4atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HTR2C known ✓ P28335 4/20 0.75
HTR2A known ✓ P28223 3/20 0.75
KMT2A known ✓ Q03164 1/20 0.51
HTR1D P28221 1/20 0.54
CDK4 P11802 4/20 0.51
CCND1 P24385 4/20 0.51
LMNA P02545 1/20 0.51
MAPK1 P28482 2/20 0.51
CYP1A2 P05177 2/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2C19 P33261 1/20 0.48
ALDH1A1 P00352 1/20 0.48
POLB P06746 1/20 0.48
HTR7 P34969 1/20 0.47
HSD17B10 Q99714 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL29435341 1.00 HTR2C (0.75) HTR2CHTR2AHTR1DCDK4CCND1
Fumaric Acid SCHEMBL29435344 0.92 HTR2A (0.62) HTR2CHTR2AHTR1DCDK4CCND1
Fumaric Acid SCHEMBL23927898 0.92 HTR2A (0.62) HTR2CHTR2AHTR1DCDK4CCND1
SCHEMBL4060777 0.87 HTR2C (1.00) HTR2CHTR2AHTR1DCDK4CCND1
Fumaric Acid SCHEMBL23927867 0.82 HTR2C (0.56) HTR2CHTR2AHTR1DHTR7
Fumaric Acid SCHEMBL23927905 0.82 HTR2A (0.56) HTR2CHTR2AHTR1DCDK4CCND1
Fumaric Acid SCHEMBL7678483 0.82 KMO (0.60) HTR2CHTR2AHTR1DHTR7
Fumaric Acid SCHEMBL23927927 0.82 HTR2A (0.49) HTR2CHTR2AHTR1DHTR7
Fumaric Acid SCHEMBL29435345 0.82 HTR2C (0.56) HTR2CHTR2AHTR1DHTR7
Fumaric Acid SCHEMBL23927936 0.81 HTR2C (0.64) HTR2CHTR2AHTR1DMAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11254640-B2 N-substituted indoles and other heterocycles for treating brain disorders THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2022-02-22 US disclosed
US-20210332012-A1 N-SUBSTITUTED INDOLES AND OTHER HETEROCYCLES FOR TREATING BRAIN DISORDERS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA CORPORATION 2021-10-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11254640-B2 N-substituted indoles and other heterocycles for treating brain disorders TPH2, AANAT, HTR2C HTR2C 3/4885HTR2A 5/4885KMT2A 542/4885
US-20210332012-A1 N-SUBSTITUTED INDOLES AND OTHER HETEROCYCLES FOR TREATING BRAIN DISORDERS TPH2, AANAT, HTR2C HTR2C 3/4885HTR2A 5/4885KMT2A 542/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.